期刊文献+

莫西沙星致不良反应165例分析 被引量:10

Analysis of 165 Adverse Drug Reactions of Moxifloxacin
原文传递
导出
摘要 目的:探讨莫西沙星所致不良反应特点及相关因素,为临床合理用药提供参考。方法:在鼓楼医院2008年5月6日-2013年5月6日上报的不良反应报表中,检索由莫西沙星引起的不良反应,对患者用药情况、性别、年龄、不良反应表现等方面进行统计分析。结果:检索到莫西沙星引起的不良反应165例,其中口服莫西沙星片所致不良反应35例,莫西沙星针剂130例,涉及消化系统、神经系统、心血管系统等系统。结论:临床应重视莫西沙星发生的不良反应,用药时注意患者的临床表现,监测患者肝、肾功能。 Objective :To analyze the adverse drug reactions caused by moxifloxacin to provide a rationale of clinical drug safety. Methods: The incidences of ADRs by propofol injection reported in the Nanjing Drum Tower Hospital from May 6,2008 to May 6, 2013 were collected. A statistical analysis based on medication, gender, age and clinical manifestation was conducted. Results: 165 cases of adverse drug reaction were collected. Of all the screened cases, ADRs caused through the oral route were 35 and ADRs through the intravenous route were 130. 165 ADRs were involved in several sys- tems such as digestive system, nervous system , cardio vascular system and so on. Conclusion:Clinical physicians should pay more attention to the patients and ensure patients'safety after moxifloxacin injection was administered. It is necessary to closely observe the laboratory examination of their blood system and to monitor their liver and kidney functions.
出处 《药物流行病学杂志》 CAS 2014年第7期428-430,共3页 Chinese Journal of Pharmacoepidemiology
关键词 莫西沙星 药品不良反应 合理用药 Moxifloxacin Adverse drug reactions Rational drug use
  • 相关文献

参考文献5

二级参考文献30

  • 1王士雯.老年多器官功能不全综合征的肺启动机制[J].中华老年多器官疾病杂志,2002,1(1):4-6. 被引量:113
  • 2陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1998.48.
  • 3[1]Schellhorn C. Classification of quinolones by Ⅴ Andriole[J]. Infection, 1998,26(1):64.
  • 4[2]Chu D T W,Fernandes P B. Structure-activity relationships of the fluoroquinolones[J]. Antimicrob Agents Chemother, 1989,33(2):131-135.
  • 5[3]Stahlmann R,Lode H. Toxicity of quinolones[J]. Drugs,1999,58(suppl.2):37-42.
  • 6[4]Stahlmann R,Schwabe R. Safety profile of grepafloxacin as compared with fluoroquinolones[J]. J Antimicrob Chemother, 1997,40(suppl.A):83-92.
  • 7[5]Stahlmann R. Safety profile of the quinolones[J]. J Antimicrob Chemother, 1990, 26 (Suppl.D):31-44.
  • 8[6]Akahane K,Sekiguchi M,Une T,et al. Structure-epileptogenicity relationships of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites[J]. Antimicrob Agents Chemother, 1989,33(10):1704-1708.
  • 9[7]Robertson D G,Epling G A,Kiely J S, et al. Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound[J]. Toxicol Appl Pharmacol, 1991,111(2):221-232.
  • 10[8]Giamarellou H,Kilokythas E,Petrikkos G,et al. Pharmacokinetics of three newer quinolones in pregnant and lactating women[J]. Am J Med, 1989,87(suppl.5A):49-51.

共引文献101

同被引文献115

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部